156 related articles for article (PubMed ID: 5629284)
1. [ATP activity of erythrocytes in children with hemolytic disease treated by exchange transfusions of Rh-positive blood].
Osipov AI
Vopr Okhr Materin Det; 1967 Jun; 12(7):23-5. PubMed ID: 5629284
[No Abstract] [Full Text] [Related]
2. [A few remarks of the immunohematologist in connection with administration of exchange transfusions in the newborn with hemolytic disease (with respect to the transfusion material)].
Kulich V; Sauer J
Cesk Gynekol; 1969 Oct; 34(8):488-90. PubMed ID: 5354332
[No Abstract] [Full Text] [Related]
3. [Significance of mixed hyperbilirubinemia in neonatal hemolytic disease caused by Rh materno-fetal isoimmunization].
Centa A
Pathologica; 1967; 59(879):513-8. PubMed ID: 5634190
[No Abstract] [Full Text] [Related]
4. [Activity of certain blood serum enzymes in hemolytic disease of the newborn treated by exchange transfusion].
Tabolin VA; Efimov MS; Uryvchikov GA; Volodin NN
Vopr Okhr Materin Det; 1974; 19(7):28-31. PubMed ID: 4471734
[No Abstract] [Full Text] [Related]
5. Imbalance of globin chain synthesis in newborn infants with hemolytic disease after exchange transfusion.
Gahr M; Jentsch E; Schföter W
Pediatr Res; 1977 Jan; 11(1 Pt 1):9-13. PubMed ID: 556652
[TBL] [Abstract][Full Text] [Related]
6. Role of IVIG in preventing exchange transfusions in Rh hemolytic disease.
Aylin T; Berkan G
Indian Pediatr; 2005 Jan; 42(1):77-9. PubMed ID: 15695869
[No Abstract] [Full Text] [Related]
7. [Behavior of erythrocytic and plasmatic neuraminic acid in newborn infants with Rh and ABO hemolytic disease].
Ambrosioni G; Serritelli G
Clin Pediatr (Bologna); 1968 Sep; 50(9):540-6. PubMed ID: 4973613
[No Abstract] [Full Text] [Related]
8. [Indices of homeostasis in newborn infants receiving replacement transfusions for treatment of hemolytic disease].
Punchenok NA
Vopr Okhr Materin Det; 1975 Jan; 20(1):18-21. PubMed ID: 1167722
[No Abstract] [Full Text] [Related]
9. Top-up transfusions in neonates with Rh hemolytic disease in relation to exchange transfusions.
Rath ME; Smits-Wintjens VE; Lindenburg I; Brand A; Oepkes D; Walther FJ; Lopriore E
Vox Sang; 2010 Jul; 99(1):65-70. PubMed ID: 20331535
[TBL] [Abstract][Full Text] [Related]
10. [A new therapeutic possibility in Rh-isoimmune hemolytic disease of the newborn. The use of Rh-positive blood based on the study of free anti-D antibody in the newborn infant. (Preliminary note)].
Pataki L; Kaiser G; Virág I; Román F
Orv Hetil; 1967 Feb; 108(8):352-4. PubMed ID: 6041608
[No Abstract] [Full Text] [Related]
11. [Gasometric studies in hemolytic disease of newborn].
Maszkiewicz W
Wiad Lek; 1976 Sep; 29(18):1617-23. PubMed ID: 988677
[No Abstract] [Full Text] [Related]
12. [Thin-layer chromatography of total lipids in hemolytic disease of the newborn (Rh and ABO). 3. Principal lipid fractions in the erythrocyte in toto in the erythrocytic stroma].
Salvioli GP; Ambrosioni G; Allocca G
Clin Pediatr (Bologna); 1968 Dec; 50(12):926-31. PubMed ID: 4979138
[No Abstract] [Full Text] [Related]
13. Endogenous formation of carbon monoxide in newborn infants. II. Rh haemolytic disease of the newborn.
Fällström SP; Bjure J
Acta Paediatr Scand; 1967 Jul; 56(4):365-73. PubMed ID: 4962671
[No Abstract] [Full Text] [Related]
14. [Hemolytic disease in a newborn infant caused by rare maternal anti-erythrocyte antibodies and exchange transfusion with maternal blood frozen earlier].
Castel A; Drejer GF; Verwey RA
Ned Tijdschr Geneeskd; 1993 Dec; 137(52):2713-5. PubMed ID: 8289944
[TBL] [Abstract][Full Text] [Related]
15. [Evaluation of the effectiveness of exchange transfusion in hemolytic disease of the newborn in view of hematological and biochemical studies].
Jasiewicz A
Zentralbl Gynakol; 1971 Jan; 93(5):168-72. PubMed ID: 5103114
[No Abstract] [Full Text] [Related]
16. [Hemolytic disease of the newborn due to Rh factor. Immediate exchange transfusion].
Pérez Murphy L; Rodríguez Mateos O; Zárate Sandoval H; Torres Ruvalcaba AB; Bailón Uriza R
Ginecol Obstet Mex; 1970 May; 27(163):575-85. PubMed ID: 5482729
[No Abstract] [Full Text] [Related]
17. [Correction of disorders of the acid-base balance in fetal and neonatal blood in hemolytic disease].
Krendel' AP
Vopr Okhr Materin Det; 1972 Sep; 17(9):61-5. PubMed ID: 4676267
[No Abstract] [Full Text] [Related]
18. Hemolytic disease of the newborn due to alloimmunization as a consequence of multiple transfusions and a delayed hemolytic transfusion reaction in the mother.
Kanra T; Erdoğan S; Yurdakök M; Erdem G
Turk J Pediatr; 1983; 25(2):129-33. PubMed ID: 6422599
[No Abstract] [Full Text] [Related]
19. Effect of screening for red cell antibodies, other than anti-D, to detect hemolytic disease of the fetus and newborn: a population study in the Netherlands.
Koelewijn JM; Vrijkotte TG; van der Schoot CE; Bonsel GJ; de Haas M
Transfusion; 2008 May; 48(5):941-52. PubMed ID: 18248570
[TBL] [Abstract][Full Text] [Related]
20. Intravenous immunoglobulin G (IVIG) therapy for significant hyperbilirubinemia in ABO hemolytic disease of the newborn.
Miqdad AM; Abdelbasit OB; Shaheed MM; Seidahmed MZ; Abomelha AM; Arcala OP
J Matern Fetal Neonatal Med; 2004 Sep; 16(3):163-6. PubMed ID: 15590442
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
